文献速递妇科产科

宫颈癌治疗后的激素替代治疗:我们是否遵循了标准诊疗?

Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?
PubMed 文献 · Gynecol Oncol · 2017-09-18

该研究评估了因宫颈癌治疗导致医源性绝经的患者接受激素替代治疗(HRT)和骨骼健康维护的实践情况。202名女性中,97名(48.0%)接受了HRT咨询和/或处方;年龄较大(调整OR 0.940,95%CI 0.890-0.993,p=0.0270)和无保险状态(调整OR 0.455,95%CI 0.212-0.977,p=0.0435)与接受HRT咨询或处方的可能性降低相关。双能X线吸收法扫描(DEXA)不频繁,仅17/197(8.6%)的女性接受。

要点

  • 202名医源性绝经的宫颈癌患者中,仅97名(48.0%)接受了HRT咨询和/或处方。
  • 年龄较大和无保险状态与接受HRT咨询或处方的可能性降低相关。
  • DEXA扫描不频繁,仅17/197(8.6%)的女性接受。

核心结论

  • 不到一半的女性在诊断医源性绝经后接受了HRT咨询和/或处方。
  • 基于保险状态存在差异。
  • 这些发现反映需要更清晰的生存期HRT指南,并改进努力以减少生存期护理分布中的差异。

研究设计与样本

  • 从弗吉尼亚大学肿瘤登记处识别2005年1月1日至2015年12月31日期间因宫颈癌治疗导致医源性绝经的女性。
  • 使用Wilcoxon秩和检验、卡方检验和Fisher精确检验进行单变量数据分析;使用逻辑回归进行多变量分析。
  • 共纳入202名女性进行分析。

主要发现

  • 97名女性(48.0%)接受了HRT咨询和/或处方。
  • 多变量分析后,诊断时年龄较大(调整OR 0.940,95%CI 0.890-0.993,p=0.0270)与接受HRT咨询或处方的可能性降低相关。
  • 无保险支付状态(调整OR 0.455,95%CI 0.212-0.977,p=0.0435)与接受HRT咨询或处方的可能性降低相关。
  • 较长的随访时间与主要结局相关,调整OR为1.011(95%CI 1.001-1.020,p=0.0252)。
  • DEXA扫描不频繁,仅17/197(8.6%)的所有女性接受。

临床怎么用

  • 作者认为,这些发现反映需要更清晰的生存期HRT指南,并改进努力以减少生存期护理分布中的差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to assess hormone replacement therapy (HRT) and bone care health maintenance practices for cervical cancer patients with iatrogenic menopause, and, secondarily, to investigate the potential impact of specific demographic and clinical factors. METHODS: Women diagnosed with iatrogenic menopause due to cervical cancer treatment between January 1, 2005 and December 31, 2015 were identified from the University of Virginia's tumor registry. Univariable data were analyzed using Wilcoxon rank sum, Chi square, and Fisher's exact test; multivariable analysis was conducted using logistic regression. RESULTS: Two hundred and two women were included for analysis. Ninety-seven of these women (48.0%) received counseling and/or a prescription for HRT. After multivariable analysis, older age at diagnosis (adjusted OR 0.940, 95% CI 0.890-0.993, p=0.0270) and uninsured payer status (adjusted OR 0.455, 95% CI 0.212-0.977, p=0.0435) were associated with a decreased likelihood of receiving counseling or a prescription for HRT. A longer duration of follow-up was associated with the primary outcome with an adjusted OR of 1.011 (95% CI 1.001-1.020, p=value 0.0252). Dual-energy X-ray absorptiometry scans (DEXA) were infrequent and received by only 17/197 (8.6%) of all women. CONCLUSIONS: Fewer than half of all women received counseling and/or a prescription for HRT after diagnoses of iatrogenic menopause, and disparities were noted based on insurance status. These findings reflect a need for clearer guidelines on HRT during survivorship and improved efforts to reduce disparities in the distribution of survivorship care.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Rauh LA, Pannone AF, Cantrell LA, et al. Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care? Gynecol Oncol. 2017. PMID: 28923411. doi:10.1016/j.ygyno.2017.09.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。